Open-label, multiple simon 2-stage study of INCB039110 administered orally to subjects with primary myelofibrosis (PMF), post polycythemia vera myelofibrosis (PPV-MF) or post essential

Project: Research

StatusFinished
Effective start/end date1/10/1230/03/13